- Home
- CHE vs PCVX Comparison
CHE vs PCVX Comparison
Compare CHE & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CHE | PCVX |
|---|---|---|
| Founded | 1970 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 6.1B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CHE | PCVX |
|---|---|---|
| Price | $373.17 | $54.69 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 7 |
| Target Price | ★ $498.00 | $98.33 |
| AVG Volume (30 Days) | 263.8K | ★ 1.1M |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 0.65% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 18.34 | N/A |
| Revenue | ★ $2,529,978,000.00 | N/A |
| Revenue This Year | $6.60 | N/A |
| Revenue Next Year | $6.15 | N/A |
| P/E Ratio | $20.09 | ★ N/A |
| Revenue Growth | ★ 4.06 | N/A |
| 52 Week Low | $365.21 | $28.09 |
| 52 Week High | $623.61 | $65.00 |
Technical Indicators
Market Signals| Indicator | CHE | PCVX |
|---|---|---|
| Relative Strength Index (RSI) | 30.31 | 46.90 |
| Support Level | N/A | $42.30 |
| Resistance Level | $458.07 | $56.04 |
| Average True Range (ATR) | 8.95 | 2.27 |
| MACD | -0.85 | -0.35 |
| Stochastic Oscillator | 18.64 | 39.05 |
Price Performance
Historical ComparisonAbout CHE Chemed Corp
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.